Raiffeisen Bank International’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Raiffeisen Bank International's BIIB Position: Q2 2026 in Review
Raiffeisen Bank International increased its Biogen (BIIB) stake by 7.6% in Q2 2026, buying an estimated $1.53K and bringing the position to 113 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #653.
Raiffeisen Bank International first reported a position in BIIB in Q4 2024 and has held it in 5 quarters since. The position peaked at $236K in Q4 2024. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Raiffeisen Bank International held 113 shares of Biogen worth $24.5K as of Q2 2026.
- Raiffeisen Bank International bought 8 Biogen shares in Q2 2026, an estimated $1.53K.
- Biogen made up ﹤0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #653 holding.
- Raiffeisen Bank International first reported a position in Biogen in Q4 2024 and has held it in 5 quarters since.
- Raiffeisen Bank International's Biogen position peaked at $236K in Q4 2024.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.